If you have diabetes, your doctor might suggest Tresiba (insulin degludec) as a treatment option for you. Tresiba is a prescription medication. It’s used long term to manage blood sugar levels in ...

Tresiba (insulin degludec) is a prescription drug that’s used to manage high blood sugar in people with diabetes. Tresiba’s cost may depend on your dosage, your health insurance, and the pharmacy you ...

Tresiba (insulin degludec) is a brand-name drug that’s prescribed for diabetes. The medication is available as a liquid vial and a prefilled injection pen. The cost of Tresiba with and without ...

The Tresiba label was updated to reflect safety outcomes from the DEVOTE trial. Novo Nordisk announced that the Food and Drug Administration (FDA) has approved an update to the prescribing information ...

BARCELONA, Spain, Sept. 19, 2019 /PRNewswire/ -- According to new data from the CONCLUDE head-to-head trial, Tresiba ® (insulin degludec) showed an overall lower risk of hypoglycaemia, also known as a ...

Bagsværd, Denmark, 29 January 2016 - Novo Nordisk today announced the headline results from SWITCH 2, the first of two 2x32-weeks randomised, double-blind, cross-over, treat-to-target trials, ...

COPENHAGEN, June 23 (Reuters) - Diabetes drugmaker Novo Nordisk on Saturday presented its findings from the real-world evidence study CONFIRM, comparing the effectiveness of its own Tresiba drug with ...

Novo Nordisk announced the submission of a supplemental application to the Food and Drug Administration (FDA) which includes data from the DEVOTE study, a trial that assessed the cardiovascular safety ...

Concern about overnight hypoglycemic events drives decision-making for patients with type 1 diabetes. For persons with type 1 diabetes (T1D) fear of the overnight hypoglycemic event drives care ...

The study's lead author said that complications from cardiovascular disease remain an unmet clinical challenge in type 2 diabetes. Insulin degludec, the ultra long-acting basal insulin from Novo ...

Adults with type 2 diabetes treated with Tresiba ® (insulin degludec injection)had asignificantreduction inHbA 1c and a 30% lower rate ...

As with other drugs, Tresiba (insulin degludec) can cause side effects, such as headache, upper respiratory infection, and injection site reaction. If side effects of Tresiba become difficult to ...